라선영 교수
#위암#신장암#방광암#육종#항암약물치료#조기임상신약치료#VIP건강검진#EBS명의
|
학력
1990 연세대학교 의과대학 학사
1994 연세대학교 의과대학 석사
1997 연세대학교 의과대학 박사
1998 미국 의사 자격 획득
1994 연세대학교 의과대학 석사
1997 연세대학교 의과대학 박사
1998 미국 의사 자격 획득
경력
1990.03-1991.02 세브란스 병원 인턴
1991.03-1995.02 세브란스 병원 내과 전공의(내과 전문의)
1995.03-1998.07 연세대 의대 내과학교실, 암센터 전임의 (혈액종양내과 전문의)
1998.08-2000.07 미국 텍사스 주립대학 부속 의과대학 암센터(Cancer Therapy and Research Center)의 전임의 (clinical and research fellow)
2001.03-2006.02 연세대학교 의과대학 암전이연구센터 조교수
2006.03-2007.02 연세대학교 의과대학 암전이연구센터 부교수
2008.03-2011.02 연세대학교 의과대학 종양내과 부교수
2009.03-2010.06 암전이연구센터 중개연구실장
2009.03-2013.02 연세의료원 암센터 종양내과 과장
2009.06-현 재 세브란스병원 피험자보호센터 소장
2009.03-현 재 대한 항암요법 연구회 비뇨/부인암 분과장
2011.03-현 재 연세대학교 의과대학 내과학교실 종양내과 교수
1991.03-1995.02 세브란스 병원 내과 전공의(내과 전문의)
1995.03-1998.07 연세대 의대 내과학교실, 암센터 전임의 (혈액종양내과 전문의)
1998.08-2000.07 미국 텍사스 주립대학 부속 의과대학 암센터(Cancer Therapy and Research Center)의 전임의 (clinical and research fellow)
2001.03-2006.02 연세대학교 의과대학 암전이연구센터 조교수
2006.03-2007.02 연세대학교 의과대학 암전이연구센터 부교수
2008.03-2011.02 연세대학교 의과대학 종양내과 부교수
2009.03-2010.06 암전이연구센터 중개연구실장
2009.03-2013.02 연세의료원 암센터 종양내과 과장
2009.06-현 재 세브란스병원 피험자보호센터 소장
2009.03-현 재 대한 항암요법 연구회 비뇨/부인암 분과장
2011.03-현 재 연세대학교 의과대학 내과학교실 종양내과 교수
논문
2021 Stable Symptom Clusters and Evolving Symptom Networks in Relation to Chemotherapy Cycles JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2021 Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis EUROPEAN JOURNAL OF CANCER
2021 Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing FRONTIERS IN PHARMACOLOGY
2021 p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer BIOCHEMICAL PHARMACOLOGY
2020 Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells Genomics & Informatics
2020 Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma NATURE GENETICS
2020 Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma DIAGNOSTICS
2020 Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2020 Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer MOLECULAR THERAPY-ONCOLYTICS
2020 Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma JOURNAL OF CLINICAL ONCOLOGY
2020 Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells YONSEI MEDICAL JOURNAL
2020 Development and evaluation of the Cancer Symptom Management System: Symptom Management Improves your LifE (SMILE)-a randomized controlled trial SUPPORTIVE CARE IN CANCER
2020 Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patients SUPPORTIVE CARE IN CANCER
2019 Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium EUROPEAN UROLOGY ONCOLOGY
2019 Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale FUTURE ONCOLOGY
2019 Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019 Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer ONCOLOGIST
2019 Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy SUPPORTIVE CARE IN CANCER
2019 A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer GASTRIC CANCER
2019 EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group BMC CANCER
2019 Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹?F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma YONSEI MEDICAL JOURNAL
2019 Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer EUROPEAN JOURNAL OF CANCER
2019 Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer GASTRIC CANCER
2019 Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2019 Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea CANCER RESEARCH AND TREATMENT
2019 Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2019 Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients Cancer Research and Treatment
2019 Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma Oncology
2019 Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2019 Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Cancer Research and Treatment
2019 Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer RADIOTHERAPY AND ONCOLOGY
2019 Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019 The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. GASTRIC CANCER
2019 S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial CANCER RESEARCH AND TREATMENT
2018 Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition CANCERS
2018 Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma BRITISH JOURNAL OF CANCER
2018 Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy BMC CANCER
2018 Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2018 Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer ANTICANCER RESEARCH
2018 Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial CLINICAL CANCER RESEARCH
2018 CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer YONSEI MEDICAL JOURNAL
2018 BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2018 Reconsideration of sample size and power calculation for overall survival in cancer clinical trials CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
2018 MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. JOURNAL OF SURGICAL ONCOLOGY
2018 Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. CANCER RESEARCH AND TREATMENT
2018 Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) GASTRIC CANCER
2018 Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial ANNALS OF SURGICAL ONCOLOGY
2018 A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy AAPS JOURNAL
2018 The prognostic value of volume-based parameters using18F-FDG PET/CT in gastric cancer according to HER2 status GASTRIC CANCER
2018 Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. KOREAN JOURNAL OF INTERNAL MEDICINE
외 395여 편
2021 Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis EUROPEAN JOURNAL OF CANCER
2021 Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing FRONTIERS IN PHARMACOLOGY
2021 p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer BIOCHEMICAL PHARMACOLOGY
2020 Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells Genomics & Informatics
2020 Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma NATURE GENETICS
2020 Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma DIAGNOSTICS
2020 Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2020 Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer MOLECULAR THERAPY-ONCOLYTICS
2020 Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma JOURNAL OF CLINICAL ONCOLOGY
2020 Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells YONSEI MEDICAL JOURNAL
2020 Development and evaluation of the Cancer Symptom Management System: Symptom Management Improves your LifE (SMILE)-a randomized controlled trial SUPPORTIVE CARE IN CANCER
2020 Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patients SUPPORTIVE CARE IN CANCER
2019 Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium EUROPEAN UROLOGY ONCOLOGY
2019 Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale FUTURE ONCOLOGY
2019 Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019 Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer ONCOLOGIST
2019 Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy SUPPORTIVE CARE IN CANCER
2019 A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer GASTRIC CANCER
2019 EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group BMC CANCER
2019 Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹?F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma YONSEI MEDICAL JOURNAL
2019 Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer EUROPEAN JOURNAL OF CANCER
2019 Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer GASTRIC CANCER
2019 Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2019 Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea CANCER RESEARCH AND TREATMENT
2019 Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2019 Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients Cancer Research and Treatment
2019 Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma Oncology
2019 Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2019 Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Cancer Research and Treatment
2019 Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer RADIOTHERAPY AND ONCOLOGY
2019 Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019 The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. GASTRIC CANCER
2019 S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial CANCER RESEARCH AND TREATMENT
2018 Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition CANCERS
2018 Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma BRITISH JOURNAL OF CANCER
2018 Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy BMC CANCER
2018 Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2018 Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer ANTICANCER RESEARCH
2018 Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial CLINICAL CANCER RESEARCH
2018 CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer YONSEI MEDICAL JOURNAL
2018 BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2018 Reconsideration of sample size and power calculation for overall survival in cancer clinical trials CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
2018 MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. JOURNAL OF SURGICAL ONCOLOGY
2018 Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. CANCER RESEARCH AND TREATMENT
2018 Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) GASTRIC CANCER
2018 Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial ANNALS OF SURGICAL ONCOLOGY
2018 A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy AAPS JOURNAL
2018 The prognostic value of volume-based parameters using18F-FDG PET/CT in gastric cancer according to HER2 status GASTRIC CANCER
2018 Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. KOREAN JOURNAL OF INTERNAL MEDICINE
외 395여 편
저서
저서 내용이 없습니다.
보도자료
위암 말기 수술 효과 놓고 의료계 논란
https://www.hankookilbo.com/News/Read/201605022132146534
20·30대 암환자 10년새 2배
http://news.chosun.com/site/data/html_dir/2013/02/14/2013021400200.html
"임상시험에서 바이오시밀러 역할 커질 듯".
http://www.monews.co.kr/news/articleView.html?idxno=212928
40년동안 치료 정체기 `연조직육종`‥'신약'으로 활기
http://medipana.com/news/news_viewer.asp?NewsNum=208140&MainKind=A&NewsKind=5&vCount=12&vKind=1
코로나가 높인 병원 문턱... 달갑잖은 암 환자 감소
https://health.chosun.com/site/data/html_dir/2020/10/06/2020100602659.html
표적 치료제 발달…‘위암 4기 진단’ 절망은 이르다
https://www.khan.co.kr/life/health/article/202103052039015#csidx75475576988a80181848ae9f0daa78a
‘면역항암제’ 만병통치약으로 오해…환자에 맞는 전문가의 치료 따라야 [의술인술]
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=032&aid=0003055470
https://www.hankookilbo.com/News/Read/201605022132146534
20·30대 암환자 10년새 2배
http://news.chosun.com/site/data/html_dir/2013/02/14/2013021400200.html
"임상시험에서 바이오시밀러 역할 커질 듯".
http://www.monews.co.kr/news/articleView.html?idxno=212928
40년동안 치료 정체기 `연조직육종`‥'신약'으로 활기
http://medipana.com/news/news_viewer.asp?NewsNum=208140&MainKind=A&NewsKind=5&vCount=12&vKind=1
코로나가 높인 병원 문턱... 달갑잖은 암 환자 감소
https://health.chosun.com/site/data/html_dir/2020/10/06/2020100602659.html
표적 치료제 발달…‘위암 4기 진단’ 절망은 이르다
https://www.khan.co.kr/life/health/article/202103052039015#csidx75475576988a80181848ae9f0daa78a
‘면역항암제’ 만병통치약으로 오해…환자에 맞는 전문가의 치료 따라야 [의술인술]
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=032&aid=0003055470
포스팅
포스팅 내용이 없습니다.
영상자료
[PEOPLE in 세브란스] 젊은이들 노리는 위암!
https://www.youtube.com/watch?v=ETKSSqSh56s
[시사기획창/미방송 인터뷰] 세브란스, 아산병원 암 치료 명의들이 말하는 구충제 / KBS뉴스(News)
https://www.youtube.com/watch?v=UPA07yLAfas
[EBS 명의] 표적, 면역 항암제의 사용 조건
https://www.youtube.com/watch?v=YCh-ujWLISE&t=275s
https://www.youtube.com/watch?v=ETKSSqSh56s
[시사기획창/미방송 인터뷰] 세브란스, 아산병원 암 치료 명의들이 말하는 구충제 / KBS뉴스(News)
https://www.youtube.com/watch?v=UPA07yLAfas
[EBS 명의] 표적, 면역 항암제의 사용 조건
https://www.youtube.com/watch?v=YCh-ujWLISE&t=275s
발표자료
고형암 환자의 항암제 치료 반응성 예측용 마커
권우선 / 김태수 / 정현철 / 라선영 / 권우선
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
위암 세포주에서의 파클리탁셀 감수성과 관련된 유전자 및 그 용도
라선영 / 정현철 / 라선영 / 노재경 / 노성훈
위암예측 유전자의 선발방법 및 그 용도
라선영 / 안성환 / 정현철 / 라선영 / 안성환 / 양상화 / 노재경
인간 디엔에이 칩 실험용 표준비교 알엔에이
라선영 / 정현철 / 라선영
인간 디엔에이 칩 실험용 표준비교 알엔에이
정현철 / 라선영
권우선 / 김태수 / 정현철 / 라선영 / 권우선
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 장암 진단용 키트
라선영 / 정현철 / 라선영 / 김남규
인간의 점액성 장암 유전자 마커
라선영 / 정현철 / 라선영 / 김남규 / 노재경
위암 세포주에서의 파클리탁셀 감수성과 관련된 유전자 및 그 용도
라선영 / 정현철 / 라선영 / 노재경 / 노성훈
위암예측 유전자의 선발방법 및 그 용도
라선영 / 안성환 / 정현철 / 라선영 / 안성환 / 양상화 / 노재경
인간 디엔에이 칩 실험용 표준비교 알엔에이
라선영 / 정현철 / 라선영
인간 디엔에이 칩 실험용 표준비교 알엔에이
정현철 / 라선영